Peptidetesting

All labs

BioPharmaSpec (Lithuania laboratory)

Public information only

A Vilnius-based laboratory offers peptide testing and has been operating since 2013. It provides a report-verification portal, though public evidence about its operations remains limited.

Listed - from four separately substantiated review fields. See them

Legal entity
Biopharmaspec, UAB
Location
Vilnius, Lithuania EU Europe
Website
biopharmaspec.com
Indicative price
On request
Report verification
Reports verifiable online
Order acceptance
Private orders on request

Four separate review fields

Existing overall assessment: Listed

The overall assessment is not an average of these four fields. Each field answers a different question and cannot offset another.

Not publicly established

Who is behind the laboratory?

The public evidence does not currently establish a responsible issuer.

Boundary: Identity and responsibility do not establish analytical competence.

View 3 signals and their evidence
Signal profile - Counts show composition, not a score. Core evidence 0 Supporting evidence 0 Boundary 3 Contradiction 0
  • Neutral No business-register entry could be found. The laboratory does not claim one.
  • Neutral Sources mention only the city (Vilnius) as the location of the Lithuanian lab; no street name, postal code, or registered address is provided in any source. Rekvizitai.lt entry does not include the registered address in the available excerpt.
  • Neutral No named real person could be documented for this laboratory; only an anonymous team.
Not publicly established

Is the procedure technically substantiated for peptides?

Public evidence does not currently substantiate competence for the relevant method and peptide matrix.

Boundary: Lack of accreditation is normal here and is not a negative signal.

View 1 signal and its evidence
Signal profile - Counts show composition, not a score. Core evidence 0 Supporting evidence 0 Boundary 1 Contradiction 0
  • Neutral No verifiable accreditation. For a laboratory that accepts private samples this is the norm, not a mark against it.
Verification offered

Can a report be traced back through the issuer?

A laboratory-controlled form or registry is available, but no qualifying specific report was confirmed.

Boundary: Report confirmation establishes neither analytical competence nor the contents of an individual vial.

View 1 signal and its evidence
Signal profile - Counts show composition, not a score. Core evidence 0 Supporting evidence 1 Boundary 0 Contradiction 0
Verification path
https://biopharmaspec.com/verify
  • Positive The laboratory offers a verification form. We could not confirm a real report through it, so this counts as an offer, not as proof.
Not publicly established

Has actual measurement performance been checked externally?

No suitable independent evidence of actual measurement performance was publicly established.

Boundary: Testimonials, report volume and average purity values are not external performance evidence.

No public signals in this review field.

Our honest take

Reports from BioPharmaSpec (Lithuania laboratory) can be treated as coming from a real, decade-old laboratory, but public evidence does not yet converge strongly enough to vouch for them at the highest level.

Positive Signals

The domain biopharmaspec.com has been registered since October 24, 2013, through registrar eNom, LLC. The laboratory explicitly lists 'Peptides and Oligonucleotides' as a molecule type and offers peptide mapping, amino acid analysis, and process-related impurity analysis for synthetic peptides, referencing FDA and EMA guidelines. A report-verification portal exists at https://biopharmaspec.com/verify, though the directory could not confirm a real report through it, so this counts as an offer rather than proof.

Why Not 'Substantiated'

The reason public evidence does not yet reach 'Substantiated' is that broader corroboration across independent public evidence dimensions is absent, and additional checkable positive evidence has not met the published depth threshold. This is distinct from neutral limits on how far this public review could go: the directory found no verified evidence of analytical competence for the relevant method and matrix, and no current independent evidence of actual analytical performance. Several open questions are on record but do not clearly justify escalation.

Open Questions and Missing Evidence

  • No business-register entry could be found and the laboratory does not claim one.
  • No verifiable accreditation was documented.
  • No named real person could be identified; only an anonymous team is referenced.
  • Sources mention only Vilnius as the location, with no street name, postal code, or registered address provided.
  • No independent reputation footprint exists in peptide or research-chemical communities.
  • The public ordering route addresses business customers only, and no prices are listed on the website.

These are signals, not a verdict.

Below: the material this assessment is built on.

Accreditation

ISO/IEC 17025: Unknown BioPharmaSpec Lithuania does not claim ISO/IEC 17025 accreditation in its own materials. No register entry found in ANAB directory or Lithuanian national accreditation body (Nacionalinis akreditacijos biuras). Company uses 'regulatory-aligned testing' and 'high-quality analytical services' language without asserting accredited status. Exhaustive negative finding across all accreditation body registers cannot be conclusively confirmed from supplied sources.

Context without a quality rating

These signals describe access, the public trail and documents. They do not colour any of the four review fields.

Audit complete

Access and offering · 3
  • Positive The lab explicitly lists 'Peptides and Oligonucleotides' as a molecule type and offers peptide mapping, amino acid analysis, and process-related impurity analysis for synthetic peptides, referencing FDA and EMA guidelines.
  • Neutral The laboratory's public ordering route addresses business customers only; no private ordering route was found.
  • Neutral No prices on the website; contact required.
Public and digital trail · 2
  • Positive The domain biopharmaspec.com was registered on October 24, 2013, according to WHOIS records from registrar eNom, LLC.
  • Neutral The provided sources contain no independent evidence regarding the reputation or track record of BioPharmaSpec's Lithuania laboratory in the peptide/research-chemical community. No forum discussions, community sentiment, complaint patterns, or enforcement actions specific to this lab are present; available information is limited to corporate self-description and general FDA warnings that do not name BioPharmaSpec.
Domain & digital trail
Domain registered
2013-10-24 (12.7 age)
Registrar
eNom, LLC
TLS
Let's Encrypt

Sources

Show all 93 sources

For lab operators

Run this lab? You can confirm the entry and correct it.

Claim this lab
This profile is built from public sources and reviewed by hand. It shows where each fact comes from. A listing is a set of signals, not an endorsement or a verdict - and never a guarantee. Presence and order cannot be purchased.
Last reviewed: 2026-07-14